Dr Malcolm Skingle

Malcolm Skingle has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry for more than 40 years and has gained a wide breadth of experience in the management of research activities. Part of his former role as a research leader in a Neuropharmacology department involved co-supervising collaborations with academics in the UK, Europe and USA. He has more than 60 publications including articles on the interface between industry and academia.

Malcolm manages Academic Liaison at GSK with staff in Stevenage and Philadelphia. His role involves close liaison with several groups outside the Company e.g. Government Departments, Research and Funding Councils and other science-driven organisations. He sits on many external bodies including several UK University Department advisory groups. He also chairs a number of groups including the Diamond (Synchotron) Industrial Advisory Board, the Cogent Science Industry Partnership Board driving skills for the life sciences sector and the ABPI group working on academic liaison.

Malcolm has also been awarded a CBE in the 2009 Queen’s Birthday Honours List in recognition of his contribution to the pharmaceutical industry as well as an Honorary Professorship from the College of Medical and Dental Sciences at the University of Birmingham; an honorary DSc from the University of Hertfordshire and honorary degree from the University of Dundee. Malcolm was elected as a Fellow into the Faculty of Medicine at Imperial College London in 2011 and an Honorary Fellow of the British Pharmacological Society in December 2020.